Mkt Cap$2.30T+3.41%
24h Vol$73.68B
BTC Dom56.3%
ETH Dom9.8%
F&G22Extreme Fear
BTC$64,560.00+4.22% ETH$1,874.01+6.28% USDT$0.9993+0.04% BNB$580.04+2.84% USDC$0.9998+0.00% XRP$1.11+4.87% SOL$77.27+3.32% TRX$0.3251-0.15% FIGR_HELOC$1.04+0.40% HYPE$65.57+3.02% DOGE$0.0744+4.38% USDS$0.9997+0.01% RAIN$0.0149+3.43% ZEC$542.75+6.51% LEO$9.55+0.43% WBT$56.79+4.40% BTC$64,560.00+4.22% ETH$1,874.01+6.28% USDT$0.9993+0.04% BNB$580.04+2.84% USDC$0.9998+0.00% XRP$1.11+4.87% SOL$77.27+3.32% TRX$0.3251-0.15% FIGR_HELOC$1.04+0.40% HYPE$65.57+3.02% DOGE$0.0744+4.38% USDS$0.9997+0.01% RAIN$0.0149+3.43% ZEC$542.75+6.51% LEO$9.55+0.43% WBT$56.79+4.40%
News

BVS

Total Stories
1
Section
BVS
Bioventus Surges with 7.6% Q4 Revenue Growth to $135.4M, Outstripping Expectations
Earnings

Bioventus Surges with 7.6% Q4 Revenue Growth to $135.4M, Outstripping Expectations

Bioventus Inc. (NASDAQ: BVS) showcased robust fourth-quarter financial performance, with a notable 7.6% increase in worldwide revenue.

Tim FriesMar 12, 20242 min read